InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
T+90 hit rate
100%
T+90 mean return
+22.1%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by YVER ANTOINE, Directeur Médical. Director active across 1 company, notably Centessa Pharmaceuticals plc. In total, 19 disclosures have been logged. Split: 0 buy · 13 sells. Total volume traded: €575k. History available since 27 May 2021. The latest transaction was filed on 1 June 2023 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
6,500 shares@ US$4.45374.3% of flowOrdinary SharesSEC:0001847903-23-000104:0
6,800 shares@ US$4.4244.4% of flowOrdinary SharesSEC:0001847903-23-000090:0
3,615 shares@ US$3.902.1% of flowOrdinary SharesSEC:0001847903-23-000082:0
7,000 shares@ US$3.42433.6% of flowOrdinary SharesSEC:0001847903-23-000054:0
77,200 shares0Ordinary SharesSEC:0001847903-23-000045:0
7,732 shares@ US$4.255.3% of flowOrdinary SharesSEC:0001847903-23-000025:0
2,268 shares@ US$3.101.0% of flowOrdinary SharesSEC:0001847903-23-000016:0
9,400 shares@ US$3.90895.6% of flowOrdinary SharesSEC:0001847903-22-000109:0
9,500 shares@ US$3.90616.0% of flowOrdinary SharesSEC:0001847903-22-000096:0
9,700 shares@ US$4.02636.3% of flowOrdinary SharesSEC:0001847903-22-000076:0
2,468 shares@ US$4.06741.6% of flowOrdinary SharesSEC:0001847903-22-000065:0
10,423 shares@ US$4.41217.4% of flowOrdinary SharesSEC:0000899243-22-030302:0
10,423 shares@ US$4.45227.2% of flowOrdinary SharesSEC:0000899243-22-027633:0
20,000 shares@ US$4.865615.3% of flowOrdinary SharesSEC:0000899243-22-026421:0
9,100 shares@ US$5.03267.0% of flowOrdinary SharesSEC:0000899243-22-025479:0
9,200 shares@ US$4.67780.0007% mcap28.2% of flowOrdinary SharesSEC:0000899243-22-023485:0
20,222 shares@ US$5.42140.0017% mcap71.8% of flowOrdinary SharesSEC:0000899243-22-018913:0
833,897 shares0Ordinary SharesSEC:0000899243-21-021436
833,897 shares0Ordinary SharesSEC:0000899243-21-021436:0
19 of 19 declarations
About YVER ANTOINE
Antoine Yver is the Chief Medical Officer and EVP & Chairman of Development at Centessa Pharmaceuticals plc. In this role, he is responsible for the company's medical strategy and product development. Centessa Pharmaceuticals is an innovation-driven biopharmaceutical company. Antoine Yver brings valuable medical and scientific expertise to guide research and development initiatives.
